May 7, 2024
James Helzberg
Share
Article Link: https://pubmed.ncbi.nlm.nih.gov/36626622/
What regimens are most effective for induction and maintenance therapy for patients with autoimmune hepatitis?
April 1, 2022
CheckMate 9DW Trial: Nivolumab + Ipilimumab for Unresectable HCC
August 17, 2026
Linerixibat for Cholestatic Pruritus in PBC: Phase 3 Results from the GLISTEN Trial
July 13, 2026
